So we could not completely rule out that the enhancement of IL‐33 on BTZ‐mediated anti‐MM efficacy was related to the effect of IL‐33 on the microenvironment,43, 44 severe combined immunodeficient mice may be more suitable for our study. This evidence concerns the gene IL33 and Miyoshi myopathy.